Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Histaminum Goutte 4ch-30ch 3 Ch Drops is a Health Canada–registered human drug (DIN 00667730) held by Dolisos Laboratoires S.a., containing Histamine. Health Canada lists its status as Cancelled Post Market (status date 09 Dec 1997). Nexara Health has matched 4 registrations of Histamine across 1 other regulated market, 1 of them in the same strength and dosage form.

Health Canada registration

DIN00667730
Brand nameHistaminum Goutte 4ch-30ch
Active ingredientHistamine
Strength3 Ch
Dosage formDrops
RouteOral
CompanyDolisos Laboratoires S.a.
StatusCancelled Post Market — 09 Dec 1997
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Histamine registered in other markets

4 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesHistamine 1522Professional Complementary Health FormulasLiquidlistedFDA NDC
United Stateshistamine positive skin test controlALK-Abello, Inc.Injection, SolutionlistedFDA NDC
United StatesHistamine Positive Skin Test ControlALK-Abello, Inc.SolutionlistedFDA NDC
United StatesPositive Skin Test Control - HistamineJubilant HollisterStier LLCInjectionlistedFDA NDC

See every manufacturer of Histamine worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Histaminum Goutte 4ch-30ch (DIN 00667730) marketed in Canada?

No. Health Canada lists DIN 00667730 as Cancelled Post Market as of 09 Dec 1997.

Who holds the Canadian licence for this product?

Dolisos Laboratoires S.a. is the company of record in the Health Canada Drug Product Database.

Is Histamine registered outside Canada?

Yes — Nexara Health has matched 4 registrations in 1 other market, including 1 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00667730, status date 1997-12-09; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00667730, status date 1997-12-09; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 00667730, status date 1997-12-09; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.